BioMedWire Stocks

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Concussions are a type of brain injury that occurs when the head is struck hard enough that the brain smacks against the skull and is damaged. Such injuries can also happen when the body is shaken violently enough to cause the brain to move around in the skull, such as during whiplash.

As with most head injuries, concussions can have major consequences if they are severe or not treated early enough. Over the long term, some patients may develop a condition called post-concussion syndrome, which is characterized by dizziness, headaches and problems with memory and concentration.

Aside from car accidents, concussions are overwhelmingly common in sports such as football and boxing, which involve a degree of physicality. According to neuroscientist professor Alan Pearce, the risk of concussive injuries in such sports has been increased by the myth that helmets are capable of protecting the wearer from these injuries.

Speaking in a recent episode of the investigative series podcast Head Noise, Pearce stated that helmets do not prevent players from sustaining concussions. Pearce told host James Graham that helmets weren’t designed to protect the brain from concussive forces. They are meant to protect the skull from lacerations and fractures, he said, but they do not have the ability to absorb all the force generated by an impact.

This means that while a helmet will prevent a wearer from sustaining broken or lacerated skull bones, it cannot prevent the brain from slamming against the inside of the skull. Given that brain tissue is delicate enough to squish through fingers, even the slightest movement can stretch the brain, placing brain cells under tension and causing them to tear against each other.

Furthermore, he explained that since the white matter and gray matter of the brain are of different densities, any impact actually causes the brain to move at two different speeds, resulting in even more strain and damage. Helmets aren’t capable of absorbing enough impact force to prevent concussions or even microdamage from occurring, Pearce said, be they hard-shell or soft-shell helmets.

In fact, helmets may actually increase the risk of concussion because they can give players a false sense of security and cause them to lower their guard, Pearce said. Furthermore, the presence of a helmet may make opposing players think they can play a little harder or sloppier because the other team is protected by helmets.

Generally, athletes wearing helmets are more likely to engage in riskier behavior than those without. When it comes to addressing the concussion crisis in sports such as the NFL, helmets are part of the problem not the solution.

At the moment, no drugs are specifically approved for concussion treatment. Companies such as Odyssey Health Inc. (OTC: ODYY) are focused on changing that through their clinical development programs, and if all goes according to plan, a remedy may soon be available to help concussion patients avoid experiencing complications that result from an untreated concussion.

NOTE TO INVESTORS: The latest news and updates relating to Odyssey Health Inc. (OTC: ODYY) are available in the company’s newsroom at https://ibn.fm/ODYY

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

New Photodynamic Therapy Offers Hope Against Brain Cancer

A planned preclinical study testing a light-activated therapy that helps to kill residual brain cancer cells after…

9 hours ago

Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies

Researchers have developed a technological platform that leverages yeast cells to test and understand new cancer treatments…

1 day ago

The Anti-Dilution Playbook: How Earth Science Tech Inc. (ETST) Rewrote the OTC Capital Structure Narrative

The company has issued zero common shares since October 2023, marking a decisive break from…

1 day ago

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell survival and treatment…

2 days ago

Policy Expert Offers Suggestions for Curbing US Health Care Costs

According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024. That figure equates…

3 days ago

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

Although CTCL may progress slowly in its early stages, it remains a chronic and ultimately…

4 days ago